Seattle Genetics (SGEN)
52.81
+1.02 +1.97%
NASDAQ
Sep 20, 16:59
Delayed 2m
USD
View All Key Stats
SGEN Key Stats
| Income Statement | |
| Revenue (TTM) | 428.94M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.43 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -203.24M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 88.56% |
| Profit Margin (Quarterly) | -52.08% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 7.553B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 17.48 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 13.17 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -67.70M |
| Return on Equity (TTM) | -32.34% |
View All SGEN News
SGEN News
-
WireHeadlineTime (ET)
-
Yahoo09/17 17:43
-
SA Breaking News09/15 08:28
-
MT Newswires09/15 07:41
-
Yahoo09/14 08:06
-
PR Newswire09/14 06:50
-
Yahoo09/13 20:28
-
Yahoo09/11 14:09
-
MT Newswires09/08 11:51
-
Yahoo09/08 10:25
-
Business Wire09/08 10:00
View All Events
SGEN Events
| Date | Type | Description |
|---|---|---|
| 07/27/2017 16:30 EDT | Misc | Seattle Genetics Inc Second Quarter Earnings Conference Call in 2017 |
| 07/27/2017 | Earnings | Seattle Genetics Inc Second Quarter Earnings in 2017 Release |
| 05/19/2017 | Misc | Seattle Genetics Inc Annual General Meeting in 2016 |
| 04/27/2017 16:30 EDT | Misc | Seattle Genetics Inc First Quarter Earnings Conference Call in 2017 |
| 04/27/2017 | Earnings | Seattle Genetics Inc First Quarter Earnings in 2017 Release |
| 02/09/2017 16:30 EST | Misc | Seattle Genetics Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/09/2017 | Earnings | Seattle Genetics Inc Fourth Quarter Earnings in 2016 Release |
| 10/27/2016 16:30 EDT | Misc | Seattle Genetics Inc Third Quarter Earnings Conference Call in 2016 |
| 10/27/2016 | Earnings | Seattle Genetics Inc Third Quarter Earnings in 2016 Release |
SGEN Fundamentals
Income Statement View Statement
SGEN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
SGEN One Page Reports
- One Page Report Download
SGEN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 52.81 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.seattlegenetics.com
- Investor Relations URL: http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-IRHome
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Jul. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Seattle Genetics Inc is a development-stage biotech company. It develops monoclonal antibody-based therapies. Its lead product, Adcetris, has received approval for relapsed/refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma.
SGEN Comparables
EditSGEN Excel Add-In Codes
- Name: =YCI("SGEN","name")
- Description: =YCI("SGEN","description")
- Sector: =YCI("SGEN","sector")
- Industry: =YCI("SGEN","industry")
- Est. Current Fiscal Year End: =YCI("SGEN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other SGEN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SGEN Tweets Stocktwits
Advertisement
